NCT04584437

Brief Summary

The human immune system is enhanced by exposure to infrared radiation with the wavelength of 5 microns to 20 microns. Humans, at normal body temperature, radiate most strongly in the infrared at a wavelength of about 10 microns. Infrared energy sustains life and can be used to treat and prevent diseases, including Covid-19 infections. High temperature within the fever range obtained from infrared radiation causes the killer T-Cells to profilate. The Killer T-Cells improves ones immune system. The high temperature kills the Corona virus. In addition, multi-vitamins and minerals including high doses of Vitamin C, increase one's immune system. Vitamin C is an anti-oxidant, produces hydrogen peroxide and removes free radicals from the body. Pre-clinical trials conducted in Houston, Texas, using Vitality Therapy or the Bible Cure were successful in curing Covid-19 infections. It is therefore possible that Vitality Therapy or the Bible Cure can be used for the successful prevention and treatment of coronavirus infections.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 14, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

May 25, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2022

Completed
Last Updated

May 17, 2021

Status Verified

May 1, 2021

Enrollment Period

12 months

First QC Date

October 9, 2020

Last Update Submit

May 13, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Treatment and Prevention of COVID-19 Pandemic.

    The Use of Infrared Energy and Vitamin C Supplement for the Treatment and Prevention of COVID-19

    10 months

Study Arms (1)

Vitality Therapy

OTHER

i. 500 to 1000 cubic centimeters of micro-clustered, hydrogen rich alkaline Vital Water. ii. Irradiation in infrared sauna for 60 minutes at high fever temperature. iii. Supplementation - Multivitamins and Minerals.

Other: Infrared Energy and Dietary Supplement

Interventions

Infrared Energy with a wavelength of 5 - 20 microns. Multivitamins and minerals including Vitamin C Supplements.

Vitality Therapy

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All humans seeking prevention or treatment of the COVID-19 pandemic.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

GAAD Medical Research Institute Inc. O/A The Centre for Incurable Diseases

Toronto, Ontario, M5V 0N7, Canada

Location

MeSH Terms

Interventions

Dietary Supplements

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prevention: The use of infrared sauna weekly will prevent COVID-19 infections. High doses of Vitamin C daily and supplements prevent Covid-19 infections. Drinking at least 4 litres of Vital Water daily will enhance ones health and prevent Covid-19 infections.. Treatment: Infrared radiation for 60 minutes or the use of higher doses of Vitamin C as supplement.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Founder and Chief Executive Officer

Study Record Dates

First Submitted

October 9, 2020

First Posted

October 14, 2020

Study Start

May 25, 2021

Primary Completion

May 10, 2022

Study Completion

July 10, 2022

Last Updated

May 17, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations